Диссертация (1140306), страница 28
Текст из файла (страница 28)
2014; 5-6.DOI: 10.1007/978-3-642-401176.249.Dai W-L, Zhou A-G, Zhang H. et al. Efficacy of platelet-rich plasma in thetreatment of knee osteoarthritis: a meta-analysis of randomized controlled trials// Arthroscopy – 2017 – 33(3) – p.659-670250.Dallari D., Stagni C., Rani N. et al. Ultrasound-Guided Injection of Platelet-RichPlasma and Hyaluronic Acid, Separately and in Combination, for HipOsteoarthritis: A Randomized Controlled Study//Am.
J. Sports Med. -2016 –44(3)–p.664-671251.Dansen, M. Therapeutic exercise for people with osteoarthritis of the hip orknee // J. Rhevmatol. 2002. - № 29 (8). - P. 1737-1745.252.Dawson J. Questionnaire on the perceptions of patients about total kneereplacement / J. Dawson, R. Fitzpatrick, D. Murray, A. Carr//Journal of boneand joint surgery British volume, 1998. - Vol. 80. №1.-P 63-69253.de Vries-van Melle M.L., Narcisi R., Kops N.
et al. Chondrogenesis ofmesenchymal stem cells in an osteochondral environment is mediated by thesubchondral bone // Tissue Eng Part A. ‒ 2014. ‒ Vol. 20, № 1-2. ‒ P. 23-33.254.DeLong J.M., Russell R.P., Mazzocca A.D. Platelet-rich plasma: the PAWclassification system // Arthroscopy. ‒ 2012. ‒ Vol. 28, № 7. ‒ P. 998-1009.255.Dieterich J.D., Fields A.C., Moucha C.S. Short term outcomes of revision totalknee arthroplasty.
// J. Arthroplast. – 2014; 29: 2163–6.256.Divine J.G., Zazulak B.T., Hewett T.E. Viscosupplementation for kneeosteoarthritis: a systematic review // Clin Orthop Relat Res. ‒ 2007. ‒ Vol. 455. ‒P. 113-122.182257.Dohan Ehrenfest D.M., Andia I., Zumstein M.A. et al. Classification ofplatelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) fortopical and infiltrative use in orthopedic and sports medicine: currentconsensus, clinical implications and perspectives//Muscles Ligaments TendonsJ.‒ 2014 ‒Vol.4,№1 ‒ P.3-9258.Dohan Ehrenfest D.M., Rasmusson L., Albrektsson T.
Classification of plateletconcentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and plateletrich fibrin (L-PRF) // Trends Biotechnol. ‒ 2009. ‒ Vol. 27, № 3. ‒ P. 158-167.259.Dold A.P., Zywiel M.G., Taylor D.W. et al. Platelet-rich plasma in themanagement of articular cartilage pathology: a systematic review // Clin J SportMed. ‒ 2014.
‒ Vol. 24, № 1. ‒ P. 31-43.260. Drengk A., Zapf A., Sturmer E.K. et al. Influence of platelet-rich plasma onchondrogenicdifferentiationandproliferationofchondrocytesandmesenchymal stem cells // Cells Tissues Organs. ‒ 2009. ‒ Vol. 189, № 5. ‒ P.317326.261.Duif C., Vogel T., Topcuoglu F. et al. Does intraoperative application ofleukocyte-poor platelet-rich plasma during arthroscopy for knee degenerationaffect postoperative pain, function and quality of life? A 12-month randomizedcontrolled double-blind trial // Arch. Orthop. Trauma Surg. – 2015 – Vol.135(7).
–P.971-977.262.Ehrenfest D.M., Bielecki T., Mishra A., et.al. In search of a consensus,terminology in the field of platelet concentrates for surgical use: platelet-richplasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization andleukocytes // Curr Pharm Biotechnol 2012; 13 (7): 1131–1137.263.El-Sharkawy H., Kantarci A., Deady J. et al.
Platelet-rich plasma: growthfactors and pro- and anti-inflammatory properties // J Periodontol. ‒ 2007. ‒Vol. 78, № 4. ‒ P. 661-669.264.Englund M., Guermazi A., Gale D., et al. Incidental meniscal findings on kneeMRI in middle-aged and elderly persons. // N. Engl. J. Med. – 2008; 359(11):1108–15.183265.Eppley B.L., Woodell J.E., Higgins J. Platelet quantification and growth factoranalysis from platelet-rich plasma: implications for wound healing // PlastReconstr Surg.
‒ 2004. ‒ Vol. 114, № 6. ‒ P. 1502-1508.266.Felson D. T. An update on the pathogenesis and epidemiology of osteoarthritis// Radiol. Clin. North Am. – 2004; 42(1): 1–9.267.Felson D.T., Naimark A., Anderson J., Kazis L., Castelli W., Meenan R.F. Theprevalence of knee osteoarthritis in the elderly. The Framingham OsteoarthritisStudy.
// Arthritis Rheum. – 1987; 30(8): 914–8.268.Filardo G., Kon E., Di Martino A. et al. Platelet-rich plasma vs hyaluronic acid totreat knee degenerative pathology: study design and preliminary results of arandomized controlled trial // BMC Musculoskelet Disord. ‒ 2012 ‒ Vol.13 ‒ P.229269.Filardo G., Kon E., Roffi A. et al. Platelet-rich plasma: why intraarticular? Asystematic review of preclinical studies and clinical evidence on PRP for jointdegeneration // Knee Surg Sports Traumatol Arthrosc. ‒ 2015. – Vol.23 (9).
–P.2459-2474.270.Flad H.D., Brandt E. Platelet-derived chemokines: pathophysiology andtherapeutic aspects // Cell Mol Life Sci. ‒ 2010. ‒ Vol. 67, № 14. ‒ P. 23632386.271.Forogh B., Mianehsaz E., Shoaee S. et al. Effect of single injection of PlateletRich Plasma in comparison with corticosteroid on knee osteoarthritis: a doubleblind randomized clinical trial // J Sports Med Phys Fitness. ‒ Epub. 2015. Jul 14.272. Foster T.E., Puskas B.L., Mandelbaum B.R.
et al. Platelet-rich plasma: frombasic science to clinical applications //Am.J.Sports Med.– 2009 – Vol.37(11) –P.2259-72.273.Fuerst M., Mohl H., Baumgartel K., Ruther W. Leflunomid increases the riskof early healing complications in patients with rheumatoid arthritis undergoingelective orthopedic. // Rheumatol. Int. – 2006; 26(12): 1138–42.184274.Fukava T., Yamaguchi S., Akatsu J.
et al. Safety and efficacy of intra-articularinjection of platelet-rich plasma in patients with ankle osteoarthritis // FootAnkle Int. – 2017 – 38(6) p. 596-604275.Fukui N., Yamane S., Ishida S., et al. Relationship between radiographicchanges and symptoms or physical examination findings in subjects withsymptomatic medial knee osteoarthritis: a three-year prospective study. // BMCMusculoskelet. Disord. – 2010; 11: 269.276.Gauffin H, Tagesson S, Meunier A, Magnusson H, Kvist J. Knee arthroscopicsurgery is beneficial to middle-aged patients with meniscal symptoms: aprospective, randomised, single-blinded study.//Osteoarthritis Cartilage–2014;22:1808–16.277.Ghosh P., Guidolin D.
Potential mechanism of action of intra-articularhyaluronan therapy in osteoarthritis: are the effects molecular weightdependent? // Semin Arthritis Rheum. ‒ 2002. ‒ Vol. 32, № 1. ‒ P. 10-37.278.Gimbel J, Brugger A, Zhao W et al. Efficacy and tolerability of Celecoxibversus Hydrocodone/Acetaminophen in treatment of pain after ambulatoryorthopedic surgery in adults. Clinic Therapeutic, 2001, V23, (#2), 228-41.279.Gioe T.J., Killeen K.K., Grimm K., Mehle S., Scheltema K. Why are totalknee replacements revised? Analysis of early revision in a community kneeimplant registry. // Clin. Orthop. Relat.
Res. – 2004; 428: 100–6.280.Gobbi A., Karnatzikos G., Mahajan V. et al. Platelet-rich plasma treatment insymptomatic patients with knee osteoarthritis: preliminary results in a group ofactive patients // Sports Health. ‒ 2012. ‒ Vol. 4, № 2. ‒ P. 162-172.281.Gobbi A., Lad D., Karnatzikos G. The effects of repeated intra-articular PRPinjections on clinical outcomes of early osteoarthritis of the knee // Knee SurgSports Traumatol Arthrosc. ‒ 2015. ‒ Vol.
23, № 8. ‒ P. 2170-2177.282.Goisis M, Stella E, Di Petrillo A, Rosset L. Nanofat Grafting Compared toHyaluronic Acid and PRP Treatment of the Lower Lid and Tear Trough:Clinical Outcome. JSM Ophthalmology 2015; 3(1):1027.185283.Goisis M, Stella E, Di Petrillo A. Malar Area. In: Injections in AestheticMedicine: Springer; 2014:73-88.284.Gormeli G., Gormeli C., Ataoglu B.
et al. Multiple PRP injections are moreeffective than single injections and hyaluronic acid in knees with earlyosteoarthritis: a randomized, double-blind, placebo-controlled trial // KneeSurg. Sports Traumatol. Arthrosc. - 2015. - Aug 2. [Epub ahead of print]285.Gottwald R., Weiser M. Treatment of osteoarthritis of the knee with Zeel T //Medicina Biologica. – 2000; 13 (4): 109–13.286.Graham DJ, Campen DH, Hui R et al. Risk of acute myocardial infarction andsudden cardiac death in patients treated with cyclo-oxygenase 2 selective andnon-selective non-steroidal anti-inflammatory drugs//Lancet. 2005; 365:475-81.287.Grozovsky R, Hoffmeister KM, Falet H.
Novel clearance mechanisms ofplatelets. Curr Opin Hematol. 2010; 17(60:585-589. DOI: 10.1097/MOH.0b013e32833e7561.288.Guermazi A., Zaim S., Taouli B., et al. MR findings in knee osteoarthritis. //Eur. Radiol. – 2003; 13: 1370–86.289.Hame S.L., Nguyen V., Ellerman J., Ngo S.S., Wang J.C., Gamradt S.C.Complications of arthroscopic meniscectomy in the older population. // Am. J.Sports Med. – 2012; 40: 1402–5.290.Hamel M.B., Toth M., Legedza A. Joint replacement surgery in elderly patientswith severe osteoarthritis of the hip or knee: decision-making, postoperativerecovery, and clinical outcomes.
// Arch. Intern. Med. – 2008; 168 (13): 1430–40.291.Halpern B., Chaudhury S., Rodeo S.A. et al. Clinical and MRI outcomes afterplatelet-rich plasma treatment for knee osteoarthritis // Clin J Sport Med. ‒2013. ‒ Vol. 23, № 3. ‒ P. 238-239.292.Hamilton D.F., Howie C.R., Burnett R., Simpson A.H., Patton J.T. Dealingwith the predicted increase in demand for revision total knee arthroplasty:challenges, risks and opportunities.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
